263 related articles for article (PubMed ID: 30452219)
1. DNA-Encoded Library-Derived DDR1 Inhibitor Prevents Fibrosis and Renal Function Loss in a Genetic Mouse Model of Alport Syndrome.
Richter H; Satz AL; Bedoucha M; Buettelmann B; Petersen AC; Harmeier A; Hermosilla R; Hochstrasser R; Burger D; Gsell B; Gasser R; Huber S; Hug MN; Kocer B; Kuhn B; Ritter M; Rudolph MG; Weibel F; Molina-David J; Kim JJ; Santos JV; Stihle M; Georges GJ; Bonfil RD; Fridman R; Uhles S; Moll S; Faul C; Fornoni A; Prunotto M
ACS Chem Biol; 2019 Jan; 14(1):37-49. PubMed ID: 30452219
[TBL] [Abstract][Full Text] [Related]
2. Loss of collagen-receptor DDR1 delays renal fibrosis in hereditary type IV collagen disease.
Gross O; Girgert R; Beirowski B; Kretzler M; Kang HG; Kruegel J; Miosge N; Busse AC; Segerer S; Vogel WF; Müller GA; Weber M
Matrix Biol; 2010 Jun; 29(5):346-56. PubMed ID: 20307660
[TBL] [Abstract][Full Text] [Related]
3. Discoidin domain receptor 1 activation links extracellular matrix to podocyte lipotoxicity in Alport syndrome.
Kim JJ; David JM; Wilbon SS; Santos JV; Patel DM; Ahmad A; Mitrofanova A; Liu X; Mallela SK; Ducasa GM; Ge M; Sloan AJ; Al-Ali H; Boulina M; Mendez AJ; Contreras GN; Prunotto M; Sohail A; Fridman R; Miner JH; Merscher S; Fornoni A
EBioMedicine; 2021 Jan; 63():103162. PubMed ID: 33340991
[TBL] [Abstract][Full Text] [Related]
4. Selective pharmacological inhibition of DDR1 prevents experimentally-induced glomerulonephritis in prevention and therapeutic regime.
Moll S; Yasui Y; Abed A; Murata T; Shimada H; Maeda A; Fukushima N; Kanamori M; Uhles S; Badi L; Cagarelli T; Formentini I; Drawnel F; Georges G; Bergauer T; Gasser R; Bonfil RD; Fridman R; Richter H; Funk J; Moeller MJ; Chatziantoniou C; Prunotto M
J Transl Med; 2018 Jun; 16(1):148. PubMed ID: 29859097
[TBL] [Abstract][Full Text] [Related]
5. Collagen receptors integrin alpha2beta1 and discoidin domain receptor 1 regulate maturation of the glomerular basement membrane and loss of integrin alpha2beta1 delays kidney fibrosis in COL4A3 knockout mice.
Rubel D; Frese J; Martin M; Leibnitz A; Girgert R; Miosge N; Eckes B; Müller GA; Gross O
Matrix Biol; 2014 Feb; 34():13-21. PubMed ID: 24480069
[TBL] [Abstract][Full Text] [Related]
6. The role of discoidin domain receptor 2 in the renal dysfunction of alport syndrome mouse model.
Sannomiya Y; Kaseda S; Kamura M; Yamamoto H; Yamada H; Inamoto M; Kuwazuru J; Niino S; Shuto T; Suico MA; Kai H
Ren Fail; 2021 Dec; 43(1):510-519. PubMed ID: 33706638
[TBL] [Abstract][Full Text] [Related]
7. Discoidin domain receptor 1 kinase activity is required for regulating collagen IV synthesis.
Borza CM; Su Y; Tran TL; Yu L; Steyns N; Temple KJ; Skwark MJ; Meiler J; Lindsley CW; Hicks BR; Leitinger B; Zent R; Pozzi A
Matrix Biol; 2017 Jan; 57-58():258-271. PubMed ID: 27915093
[TBL] [Abstract][Full Text] [Related]
8. Glomerular basement membrane deposition of collagen α1(III) in Alport glomeruli by mesangial filopodia injures podocytes via aberrant signaling through DDR1 and integrin α2β1.
Madison J; Wilhelm K; Meehan DT; Delimont D; Samuelson G; Cosgrove D
J Pathol; 2022 Sep; 258(1):26-37. PubMed ID: 35607980
[TBL] [Abstract][Full Text] [Related]
9. Preemptive ramipril therapy delays renal failure and reduces renal fibrosis in COL4A3-knockout mice with Alport syndrome.
Gross O; Beirowski B; Koepke ML; Kuck J; Reiner M; Addicks K; Smyth N; Schulze-Lohoff E; Weber M
Kidney Int; 2003 Feb; 63(2):438-46. PubMed ID: 12631109
[TBL] [Abstract][Full Text] [Related]
10. The Extracellular Matrix Receptor Discoidin Domain Receptor 1 Regulates Collagen Transcription by Translocating to the Nucleus.
Chiusa M; Hu W; Liao HJ; Su Y; Borza CM; de Caestecker MP; Skrypnyk NI; Fogo AB; Pedchenko V; Li X; Zhang MZ; Hudson BG; Basak T; Vanacore RM; Zent R; Pozzi A
J Am Soc Nephrol; 2019 Sep; 30(9):1605-1624. PubMed ID: 31383731
[TBL] [Abstract][Full Text] [Related]
11. Nephroprotective effect of the HMG-CoA-reductase inhibitor cerivastatin in a mouse model of progressive renal fibrosis in Alport syndrome.
Koepke ML; Weber M; Schulze-Lohoff E; Beirowski B; Segerer S; Gross O
Nephrol Dial Transplant; 2007 Apr; 22(4):1062-9. PubMed ID: 17287218
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of EP300 and DDR1 synergistically alleviates pulmonary fibrosis in vitro and in vivo.
Tao J; Zhang M; Wen Z; Wang B; Zhang L; Ou Y; Tang X; Yu X; Jiang Q
Biomed Pharmacother; 2018 Oct; 106():1727-1733. PubMed ID: 30119248
[TBL] [Abstract][Full Text] [Related]
13. A human-mouse chimera of the alpha3alpha4alpha5(IV) collagen protomer rescues the renal phenotype in Col4a3-/- Alport mice.
Heidet L; Borza DB; Jouin M; Sich M; Mattei MG; Sado Y; Hudson BG; Hastie N; Antignac C; Gubler MC
Am J Pathol; 2003 Oct; 163(4):1633-44. PubMed ID: 14507670
[TBL] [Abstract][Full Text] [Related]
14. DDR1: A major player in renal diseases.
Dorison A; Chantziantoniou C
Cell Adh Migr; 2018; 12(4):299-304. PubMed ID: 29455614
[TBL] [Abstract][Full Text] [Related]
15. Progression of Alport Kidney Disease in Col4a3 Knock Out Mice Is Independent of Sex or Macrophage Depletion by Clodronate Treatment.
Kim M; Piaia A; Shenoy N; Kagan D; Gapp B; Kueng B; Weber D; Dietrich W; Ksiazek I
PLoS One; 2015; 10(11):e0141231. PubMed ID: 26555339
[TBL] [Abstract][Full Text] [Related]
16. CG200745, a Novel HDAC Inhibitor, Attenuates Kidney Fibrosis in a Murine Model of Alport Syndrome.
Suh SH; Choi HS; Kim CS; Kim IJ; Cha H; Cho JM; Ma SK; Kim SW; Bae EH
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32098220
[TBL] [Abstract][Full Text] [Related]
17. Osteopontin deficiency ameliorates Alport pathology by preventing tubular metabolic deficits.
Ding W; Yousefi K; Goncalves S; Goldstein BJ; Sabater AL; Kloosterboer A; Ritter P; Lambert G; Mendez AJ; Shehadeh LA
JCI Insight; 2018 Mar; 3(6):. PubMed ID: 29563333
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological evaluation of novel dasatinib analogues as potent DDR1 and DDR2 kinase inhibitors.
Liu L; Hussain M; Luo J; Duan A; Chen C; Tu Z; Zhang J
Chem Biol Drug Des; 2017 Mar; 89(3):420-427. PubMed ID: 27589335
[TBL] [Abstract][Full Text] [Related]
19. Stage-specific action of matrix metalloproteinases influences progressive hereditary kidney disease.
Zeisberg M; Khurana M; Rao VH; Cosgrove D; Rougier JP; Werner MC; Shield CF; Werb Z; Kalluri R
PLoS Med; 2006 Apr; 3(4):e100. PubMed ID: 16509766
[TBL] [Abstract][Full Text] [Related]
20. Discoidin Domain Receptor 1 Mediates Myosin-Dependent Collagen Contraction.
Coelho NM; Arora PD; van Putten S; Boo S; Petrovic P; Lin AX; Hinz B; McCulloch CA
Cell Rep; 2017 Feb; 18(7):1774-1790. PubMed ID: 28199848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]